Form 8-K - Current report:
SEC Accession No. 0001731122-23-001210
Filing Date
2023-06-27
Accepted
2023-06-26 17:56:24
Documents
14
Period of Report
2023-06-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e4828_8k.htm   iXBRL 8-K 45034
2 EXHIBIT 10.1 e4828_ex10-1.htm EX-10.1 216831
3 EXHIBIT 10.2 e4828_ex10-2.htm EX-10.2 86847
  Complete submission text file 0001731122-23-001210.txt   600812

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE enob-20230620.xsd EX-101.SCH 3024
5 XBRL LABEL FILE enob-20230620_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE enob-20230620_pre.xml EX-101.PRE 22365
8 EXTRACTED XBRL INSTANCE DOCUMENT e4828_8k_htm.xml XML 3327
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
Enochian Biosciences Inc (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38758 | Film No.: 231043482
SIC: 2834 Pharmaceutical Preparations